Skip to main content
. Author manuscript; available in PMC: 2012 Dec 15.
Published in final edited form as: Blood Cells Mol Dis. 2011 Aug 30;47(4):249–254. doi: 10.1016/j.bcmd.2011.07.006

Table 5.

Hepatic Uroporphyringen Decarboxylase and rhUROD-Inhibitor Activities in Cytosolic Fractions of Cyp1a2−/−;Hfe−/−;Urod+/− Mice After Treatment Regimens Consisting Variously of High Iron Diet, Iron-dextran and PCB injections and δ-Aminolevulinic acid-containing Drinking Water

UROD Activity and Cytosolic Inhibitor
mouse Treatment 2 Treatment 3 Treatment 4 Treatment 5
Fe-diet Fe-diet ala/fedex Fe-diet pcb/ala Fe-diet pcb/ala/fedex
UROD activity (nmol/mg cytosolic protein/h) #1 0.63 0.13 0.17 0.12
#2 0.55 0.24 0.49 0.29
#3 0.87 0.43 0.17 0.77
#4 0.73 0.42 0.51 0.75
#5 0.94 0.76
#6 0.71 0.72
rhUROD inhibition (%) #1 9.0 36.0 22.1 35.8
#2 8.0 23.3 10.7 20.3
#3 6.6 21.0 16.6 9.4
#4 4.1 14.0 6.7 7.2
#5 7.7 14.6
#6 12.7 12.4

Mice fed a high iron diet (fe-diet, 2 mg Fe/g) after weaning > 14 weeks and were sacrificed 4 weeks after receiving any of additional treatments indicated. “Fedex” was a single injection of aqueous iron dextran (10 mg, ip), “ala” was δ-aminolevulinic acid (2 mg/ml) provided continuously in the drinking water and “pcb” was a single injection of Aroclor 1254, (4 mg, ip in corn oil). Values for animals are arranged in the same order as the male Cyp1a2−/− Hfe−/− Urod+/− group in Table 2.